IL6 and cancer: To explore the relationship between IL-6 and CTL in cancer patients, we selected patients from the IMmotion150 (RCC) and IMvigor210 (UC) trials with high (>10 pg/mL) or low plasma IL-6 and performed 10x single-cell RNA sequencing of their pre-treatment peripheral blood mononuclear cells.